A Chinese drug maker scores a big clinical trial win with a novel diabetes therapy - STAT

A Chinese drug maker scores a big clinical trial win with a novel diabetes therapy - STAT

More reads

• A Chinese drug maker scores a big clinical trial win with a novel diabetes therapy. (STAT Plus)
• Biotech analysts see return to normal after virus-driven frenzy. (Bloomberg)
• Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs. (STAT Plus)
• What's the hard cost of a pivotal drug trial? A lot less than you might expect. (Endpoints)